Melatonin, a common over-the-counter supplement used as a sleep aid, could be a potential treatment option for patients with COVID-19, according to a study from Cleveland Clinic.
The study comes from the clinic’s Lerner Research Institute and focuses on the re-purposing of drugs that the U.S. Food and Drug Administration approved for new therapeutic uses.